In the last 12 months, insiders at HAEMONETICS CORP ($HAE) filed 143 transactions with the SEC: 1 open-market purchases totaling $98,784 and 15 sales totaling $3,461,423. Net insider sentiment: net selling.
HAEMONETICS CORP operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Simon, Christopher (President & CEO) — 18 transactions totaling $20,775,201
- Basil Michelle L (EVP and General Counsel) — 20 transactions totaling $3,478,419
- Strong Stewart W (President, Global Hospital) — 19 transactions totaling $2,627,490
- Lingamneni Anila (EVP, Chief Technology Officer) — 11 transactions totaling $1,035,375
- Llorens Josep (EVP, Global Manufacturing) — 9 transactions totaling $758,017
View all SEC Filings for HAEMONETICS CORP (HAE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 10, 2025 | KROLL MARK W | Director | P | Common Stock | 1400 | $70.56 | 24,757.0000 | 48,009,000 | 5.99% | 0.00% |
| Oct. 31, 2025 | Galvin Roy | EVP, Chief Commercial Officer | F | Common Stock | 145 | $50.01 | 12,811.0000 | 48,009,000 | 1.12% | 0.00% |
| Sept. 17, 2025 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 238 | $49.95 | 28,925.0000 | 50,730,000 | 0.82% | 0.00% |
| July 24, 2025 | Dockendorff Charles J | Director | A | Common Stock | 2693 | $0.00 | 25,041.0000 | 50,730,000 | 12.05% | 0.01% |
| July 24, 2025 | Johnson Lloyd Emerson | Director | A | Common Stock | 2693 | $0.00 | 12,933.0000 | 50,730,000 | 26.30% | 0.01% |
| July 24, 2025 | KROLL MARK W | Director | A | Common Stock | 2693 | $0.00 | 23,357.0000 | 50,730,000 | 13.03% | 0.01% |
| July 24, 2025 | Pomeroy Claire | Director | A | Common Stock | 2693 | $0.00 | 16,872.0000 | 50,730,000 | 18.99% | 0.01% |
| July 24, 2025 | Zane Ellen M | Director | A | Common Stock | 2693 | $0.00 | 19,373.0000 | 50,730,000 | 16.15% | 0.01% |
| July 24, 2025 | ABERNATHY ROBERT E | Director | A | Common Stock | 2693 | $0.00 | 24,981.0000 | 50,730,000 | 12.08% | 0.01% |
| July 24, 2025 | Bryant Diane M | Director | A | Common Stock | 2693 | $0.00 | 7,126.0000 | 50,730,000 | 60.75% | 0.01% |
| July 24, 2025 | COYLE MICHAEL J | Director | A | Common Stock | 2693 | $0.00 | 15,394.0000 | 50,730,000 | 21.20% | 0.01% |
| May 16, 2025 | Basil Michelle L | EVP and General Counsel | A | Common Stock | 6755 | $0.00 | 35,233.0000 | 50,730,000 | 23.72% | 0.01% |
| May 16, 2025 | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 14626 | $0.00 | 14,626.0000 | 50,730,000 | 9999.99% | 0.03% |
| May 16, 2025 | Galvin Roy | EVP, Chief Commercial Officer | A | Common Stock | 5689 | $0.00 | 12,932.0000 | 50,730,000 | 78.54% | 0.01% |
| May 16, 2025 | Galvin Roy | EVP, Chief Commercial Officer | A | Non-qualified Stock Option (Right to Buy) | 12317 | $0.00 | 12,317.0000 | 50,730,000 | 9999.99% | 0.02% |
| June 5, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 2662 | $0.00 | 4,478.0000 | 50,730,000 | 146.59% | 0.01% |
| June 5, 2025 | Miller Laurie A. | SVP, Human Resources | A | Common Stock | 3195 | $0.00 | 29,163.0000 | 50,730,000 | 12.30% | 0.01% |
| May 30, 2025 | Simon, Christopher | President & CEO | F | Common Stock | 26234 | $69.38 | 375,544.0000 | 50,730,000 | 6.53% | 0.05% |
| May 30, 2025 | Miller Laurie A. | SVP, Human Resources | A | Common Stock | 7777 | $0.00 | 28,251.0000 | 50,730,000 | 37.98% | 0.02% |
| May 30, 2025 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 2283 | $69.38 | 25,968.0000 | 50,730,000 | 8.08% | 0.00% |
| May 30, 2025 | DArecca James | EVP, Chief Financial Officer | A | Common Stock | 12221 | $0.00 | 34,156.0000 | 50,730,000 | 55.71% | 0.02% |
| May 30, 2025 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 5864 | $69.38 | 28,292.0000 | 50,730,000 | 17.17% | 0.01% |
| May 30, 2025 | Basil Michelle L | EVP and General Counsel | A | Common Stock | 15554 | $0.00 | 49,721.0000 | 50,730,000 | 45.52% | 0.03% |
| May 30, 2025 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 7469 | $69.38 | 42,252.0000 | 50,730,000 | 15.02% | 0.01% |
| May 30, 2025 | Simon, Christopher | President & CEO | A | Common Stock | 66666 | $0.00 | 401,778.0000 | 50,730,000 | 19.89% | 0.13% |
| May 16, 2025 | Simon, Christopher | President & CEO | A | Non-qualified Stock Option (Right to Buy) | 46342 | $0.00 | 46,342.0000 | 50,730,000 | 9999.99% | 0.09% |
| May 16, 2025 | DArecca James | EVP, Chief Financial Officer | A | Common Stock | 7111 | $0.00 | 21,935.0000 | 50,730,000 | 47.97% | 0.01% |
| May 16, 2025 | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 12317 | $0.00 | 12,317.0000 | 50,730,000 | 9999.99% | 0.02% |
| May 16, 2025 | Basil Michelle L | EVP and General Counsel | A | Common Stock | 5689 | $0.00 | 34,167.0000 | 50,730,000 | 19.98% | 0.01% |
| May 16, 2025 | Galvin Roy | President, Global Plasma & BC | A | Non-qualified Stock Option (Right to Buy) | 14626 | $0.00 | 14,626.0000 | 50,730,000 | 9999.99% | 0.03% |
| May 16, 2025 | Galvin Roy | President, Global Plasma & BC | A | Common Stock | 6755 | $0.00 | 13,998.0000 | 50,730,000 | 93.26% | 0.01% |
| May 16, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 800 | $0.00 | 1,816.0000 | 50,730,000 | 78.74% | 0.00% |
| May 16, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Non-qualified Stock Option (Right to Buy) | 1732 | $0.00 | 1,732.0000 | 50,730,000 | 9999.99% | 0.00% |
| May 16, 2025 | Miller Laurie A. | SVP, Human Resources | A | Common Stock | 3200 | $0.00 | 20,474.0000 | 50,730,000 | 18.52% | 0.01% |
| May 16, 2025 | Miller Laurie A. | SVP, Human Resources | A | Non-qualified Stock Option (Right to Buy) | 6928 | $0.00 | 6,928.0000 | 50,730,000 | 9999.99% | 0.01% |
| May 16, 2025 | Chan Frank | EVP, Chief Operating Officer | A | Common Stock | 5689 | $0.00 | 5,689.0000 | 50,730,000 | 9999.99% | 0.01% |
| May 16, 2025 | Chan Frank | EVP, Chief Operating Officer | A | Non-qualified Stock Option (Right to Buy) | 12317 | $0.00 | 12,317.0000 | 50,730,000 | 9999.99% | 0.02% |
| May 16, 2025 | Simon, Christopher | President & CEO | A | Common Stock | 21405 | $0.00 | 335,112.0000 | 50,730,000 | 6.82% | 0.04% |
| May 16, 2025 | DArecca James | EVP, Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 15396 | $0.00 | 15,396.0000 | 50,730,000 | 9999.99% | 0.03% |
| May 16, 2025 | Galvin Roy | President, Global Plasma & BC | F | Common Stock | 257 | $70.31 | 7,243.0000 | 50,730,000 | 3.43% | 0.00% |
| May 15, 2025 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 622 | $69.38 | 30,635.0000 | 50,730,000 | 1.99% | 0.00% |
| May 16, 2025 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 2157 | $70.31 | 28,478.0000 | 50,730,000 | 7.04% | 0.00% |
| May 15, 2025 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 622 | $69.38 | 16,070.0000 | 50,730,000 | 3.73% | 0.00% |
| May 16, 2025 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 1246 | $70.31 | 14,824.0000 | 50,730,000 | 7.75% | 0.00% |
| May 15, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 60 | $69.38 | 1,084.0000 | 50,730,000 | 5.24% | 0.00% |
| May 16, 2025 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 68 | $70.31 | 1,016.0000 | 50,730,000 | 6.27% | 0.00% |
| May 15, 2025 | Galvin Roy | President, Global Plasma & BC | F | Common Stock | 201 | $69.38 | 7,500.0000 | 50,730,000 | 2.61% | 0.00% |
| May 15, 2025 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 206 | $69.38 | 17,751.0000 | 50,730,000 | 1.15% | 0.00% |
| May 16, 2025 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 477 | $70.31 | 17,274.0000 | 50,730,000 | 2.69% | 0.00% |
| May 15, 2025 | Simon, Christopher | President & CEO | F | Common Stock | 2391 | $69.38 | 320,796.0000 | 50,730,000 | 0.74% | 0.00% |
| May 16, 2025 | Simon, Christopher | President & CEO | F | Common Stock | 7089 | $70.31 | 313,707.0000 | 50,730,000 | 2.21% | 0.01% |
| May 2, 2025 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 654 | $63.85 | 16,692.0000 | 50,730,000 | 3.77% | 0.00% |
| Nov. 1, 2024 | Galvin Roy | President, Global Plasma & BC | F | Common Stock | 161 | $71.48 | 7,373.0000 | 51,402,000 | 2.14% | 0.00% |
| Sept. 17, 2024 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 238 | $76.54 | 17,807.0000 | 51,397,000 | 1.32% | 0.00% |
| Aug. 29, 2024 | Simon, Christopher | President & CEO | J | Common Stock | 39704 | $75.56 | 322,838.0000 | 51,397,000 | 10.95% | 0.08% |
| July 26, 2024 | Strong Stewart W | President, Global Hospital | S | Common Stock | 4312 | $91.15 | 18,196.0000 | 51,397,000 | 19.16% | 0.01% |
| July 25, 2024 | Johnson Lloyd Emerson | Director | A | Common Stock | 2207 | $0.00 | 10,240.0000 | 51,397,000 | 27.47% | 0.00% |
| July 25, 2024 | Bryant Diane M | Director | A | Common Stock | 2207 | $0.00 | 4,433.0000 | 51,397,000 | 99.15% | 0.00% |
| July 25, 2024 | ABERNATHY ROBERT E | Director | A | Common Stock | 2207 | $0.00 | 22,288.0000 | 51,397,000 | 10.99% | 0.00% |
| July 25, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 2798 | $90.58 | 22,508.0000 | 51,397,000 | 11.06% | 0.01% |
| July 24, 2024 | Strong Stewart W | President, Global Hospital | A | Common Stock | 7110 | $0.00 | 25,306.0000 | 51,397,000 | 39.07% | 0.01% |
| July 25, 2024 | COYLE MICHAEL J | Director | A | Common Stock | 2207 | $0.00 | 12,701.0000 | 51,397,000 | 21.03% | 0.00% |
| July 25, 2024 | KROLL MARK W | Director | A | Common Stock | 2207 | $0.00 | 20,664.0000 | 51,397,000 | 11.96% | 0.00% |
| July 25, 2024 | Pomeroy Claire | Director | A | Common Stock | 2207 | $0.00 | 14,179.0000 | 51,397,000 | 18.43% | 0.00% |
| July 25, 2024 | Zane Ellen M | Director | A | Common Stock | 2207 | $0.00 | 16,680.0000 | 51,397,000 | 15.25% | 0.00% |
| July 25, 2024 | Dockendorff Charles J | Director | A | Common Stock | 2207 | $0.00 | 22,348.0000 | 51,397,000 | 10.96% | 0.00% |
| July 12, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | S | Common Stock | 79 | $90.00 | 21,331.0000 | 51,397,000 | 0.37% | 0.00% |
| July 11, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | S | Common Stock | 2136 | $90.00 | 21,410.0000 | 51,397,000 | 9.07% | 0.00% |
| June 6, 2024 | Simon, Christopher | President & CEO | M | Non-qualified Stock Option (Right to Buy) | 104516 | $0.00 | 0.0000 | 51,397,000 | 100.00% | 0.20% |
| June 6, 2024 | Simon, Christopher | President & CEO | F | Common Stock | 71335 | $87.38 | 362,542.0000 | 51,397,000 | 16.44% | 0.14% |
| June 6, 2024 | Simon, Christopher | President & CEO | M | Common Stock | 104516 | $41.64 | 433,877.0000 | 51,397,000 | 31.73% | 0.20% |
| May 28, 2024 | Simon, Christopher | President & CEO | F | Common Stock | 41736 | $95.73 | 329,361.0000 | 51,397,000 | 11.25% | 0.08% |
| May 28, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | A | Common Stock | 14140 | $0.00 | 28,825.0000 | 51,397,000 | 96.29% | 0.03% |
| May 28, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | F | Common Stock | 5279 | $95.73 | 23,546.0000 | 51,397,000 | 18.31% | 0.01% |
| May 28, 2024 | Llorens Josep | EVP, Global Manufacturing | A | Common Stock | 14140 | $0.00 | 35,450.0000 | 51,397,000 | 66.35% | 0.03% |
| May 28, 2024 | Llorens Josep | EVP, Global Manufacturing | F | Common Stock | 4510 | $95.73 | 30,940.0000 | 51,397,000 | 12.72% | 0.01% |
| May 28, 2024 | Basil Michelle L | EVP and General Counsel | A | Common Stock | 24748 | $0.00 | 56,005.0000 | 51,397,000 | 79.18% | 0.05% |
| May 28, 2024 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 11758 | $95.73 | 44,247.0000 | 51,397,000 | 20.99% | 0.02% |
| May 29, 2024 | Basil Michelle L | EVP and General Counsel | S | Common Stock | 8896 | $87.86 | 35,351.0000 | 51,397,000 | 20.11% | 0.02% |
| May 29, 2024 | Basil Michelle L | EVP and General Counsel | S | Common Stock | 4094 | $88.57 | 31,257.0000 | 51,397,000 | 11.58% | 0.01% |
| May 28, 2024 | Miller Laurie A. | SVP, Human Resources | A | Common Stock | 2650 | $0.00 | 18,823.0000 | 51,397,000 | 16.39% | 0.01% |
| May 28, 2024 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 778 | $95.73 | 18,045.0000 | 51,397,000 | 4.13% | 0.00% |
| May 28, 2024 | Simon, Christopher | President & CEO | A | Common Stock | 106062 | $0.00 | 371,097.0000 | 51,397,000 | 40.02% | 0.21% |
| May 28, 2024 | Strong Stewart W | President, Global Hospital | A | Common Stock | 13256 | $0.00 | 31,452.0000 | 51,397,000 | 72.85% | 0.03% |
| May 28, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 4399 | $95.73 | 27,053.0000 | 51,397,000 | 13.99% | 0.01% |
| May 29, 2024 | Strong Stewart W | President, Global Hospital | S | Common Stock | 8857 | $87.53 | 18,196.0000 | 51,397,000 | 32.74% | 0.02% |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | A | Non-qualified Stock Option (Right to Buy) | 9183 | $0.00 | 9,183.0000 | 51,397,000 | 9999.99% | 0.02% |
| May 17, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | F | Common Stock | 349 | $95.73 | 11,291.0000 | 51,397,000 | 3.00% | 0.00% |
| May 17, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | A | Common Stock | 3394 | $0.00 | 14,685.0000 | 51,397,000 | 30.06% | 0.01% |
| May 17, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | A | Non-qualified Stock Option (Right to Buy) | 7461 | $0.00 | 7,461.0000 | 51,397,000 | 9999.99% | 0.01% |
| May 17, 2024 | Llorens Josep | EVP, Global Manufacturing | S | Common Stock | 822 | $94.82 | 16,350.0000 | 51,397,000 | 4.79% | 0.00% |
| May 17, 2024 | Llorens Josep | EVP, Global Manufacturing | F | Common Stock | 320 | $95.73 | 16,030.0000 | 51,397,000 | 1.96% | 0.00% |
| May 17, 2024 | Llorens Josep | EVP, Global Manufacturing | A | Common Stock | 6267 | $0.00 | 22,297.0000 | 51,397,000 | 39.10% | 0.01% |
| May 20, 2024 | Llorens Josep | EVP, Global Manufacturing | S | Common Stock | 987 | $95.08 | 21,310.0000 | 51,397,000 | 4.43% | 0.00% |
| May 17, 2024 | Galvin Roy | President, Global Plasma & BC | A | Common Stock | 2872 | $0.00 | 7,410.0000 | 51,397,000 | 63.29% | 0.01% |
| May 17, 2024 | Galvin Roy | President, Global Plasma & BC | A | Non-qualified Stock Option (Right to Buy) | 6313 | $0.00 | 6,313.0000 | 51,397,000 | 9999.99% | 0.01% |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | S | Common Stock | 1073 | $95.00 | 29,352.0000 | 51,397,000 | 3.53% | 0.00% |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 669 | $95.73 | 28,683.0000 | 51,397,000 | 2.28% | 0.00% |
| May 17, 2024 | Basil Michelle L | EVP and General Counsel | A | Common Stock | 4178 | $0.00 | 32,861.0000 | 51,397,000 | 14.57% | 0.01% |
| May 20, 2024 | Basil Michelle L | EVP and General Counsel | S | Common Stock | 1604 | $95.08 | 31,257.0000 | 51,397,000 | 4.88% | 0.00% |
| May 17, 2024 | Miller Laurie A. | SVP, Human Resources | A | Non-qualified Stock Option (Right to Buy) | 4591 | $0.00 | 4,591.0000 | 51,397,000 | 9999.99% | 0.01% |
| May 17, 2024 | DArecca James | EVP, Chief Financial Officer | A | Common Stock | 4439 | $0.00 | 17,346.0000 | 51,397,000 | 34.39% | 0.01% |
| May 17, 2024 | DArecca James | EVP, Chief Financial Officer | A | Non-qualified Stock Option (Right to Buy) | 9756 | $0.00 | 9,756.0000 | 51,397,000 | 9999.99% | 0.02% |
| May 17, 2024 | Simon, Christopher | President & CEO | F | Common Stock | 4037 | $95.73 | 250,411.0000 | 51,397,000 | 1.59% | 0.01% |
| May 17, 2024 | Simon, Christopher | President & CEO | A | Common Stock | 14624 | $0.00 | 265,035.0000 | 51,397,000 | 5.84% | 0.03% |
| May 17, 2024 | Simon, Christopher | President & CEO | A | Non-qualified Stock Option (Right to Buy) | 32140 | $0.00 | 32,140.0000 | 51,397,000 | 9999.99% | 0.06% |
| May 17, 2024 | Miller Laurie A. | SVP, Human Resources | A | Common Stock | 2089 | $0.00 | 16,173.0000 | 51,397,000 | 14.83% | 0.00% |
| May 17, 2024 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 76 | $95.73 | 14,084.0000 | 51,397,000 | 0.54% | 0.00% |
| May 20, 2024 | Strong Stewart W | President, Global Hospital | M | Non-qualified Stock Option (Right to Buy) | 2241 | $0.00 | 2,242.0000 | 51,397,000 | 49.99% | 0.00% |
| May 17, 2024 | Strong Stewart W | President, Global Hospital | A | Non-qualified Stock Option (Right to Buy) | 6313 | $0.00 | 6,313.0000 | 51,397,000 | 9999.99% | 0.01% |
| May 20, 2024 | Strong Stewart W | President, Global Hospital | S | Common Stock | 686 | $95.11 | 18,196.0000 | 51,397,000 | 3.63% | 0.00% |
| May 20, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 1555 | $95.08 | 18,882.0000 | 51,397,000 | 7.61% | 0.00% |
| May 20, 2024 | Strong Stewart W | President, Global Hospital | M | Common Stock | 2241 | $56.57 | 20,437.0000 | 51,397,000 | 12.32% | 0.00% |
| May 17, 2024 | Strong Stewart W | President, Global Hospital | A | Common Stock | 2872 | $0.00 | 18,196.0000 | 51,397,000 | 18.74% | 0.01% |
| May 17, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 284 | $95.73 | 15,324.0000 | 51,397,000 | 1.82% | 0.00% |
| May 17, 2024 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Non-qualified Stock Option (Right to Buy) | 1291 | $0.00 | 1,291.0000 | 51,397,000 | 9999.99% | 0.00% |
| May 17, 2024 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | A | Common Stock | 587 | $0.00 | 1,144.0000 | 51,397,000 | 105.39% | 0.00% |
| May 15, 2024 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 233 | $96.49 | 14,393.0000 | 51,397,000 | 1.59% | 0.00% |
| May 16, 2024 | Miller Laurie A. | SVP, Human Resources | F | Common Stock | 233 | $94.80 | 14,160.0000 | 51,397,000 | 1.62% | 0.00% |
| May 15, 2024 | Llorens Josep | EVP, Global Manufacturing | F | Common Stock | 258 | $96.49 | 18,205.0000 | 51,397,000 | 1.40% | 0.00% |
| May 16, 2024 | Llorens Josep | EVP, Global Manufacturing | F | Common Stock | 263 | $94.80 | 17,942.0000 | 51,397,000 | 1.44% | 0.00% |
| May 16, 2024 | Llorens Josep | EVP, Global Manufacturing | S | Common Stock | 770 | $96.14 | 17,172.0000 | 51,397,000 | 4.29% | 0.00% |
| May 15, 2024 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 412 | $96.49 | 13,258.0000 | 51,397,000 | 3.01% | 0.00% |
| May 16, 2024 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 351 | $94.80 | 12,907.0000 | 51,397,000 | 2.65% | 0.00% |
| May 15, 2024 | Simon, Christopher | President & CEO | F | Common Stock | 1480 | $96.49 | 256,355.0000 | 51,397,000 | 0.57% | 0.00% |
| May 16, 2024 | Simon, Christopher | President & CEO | F | Common Stock | 1907 | $94.80 | 254,448.0000 | 51,397,000 | 0.74% | 0.00% |
| May 15, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | F | Common Stock | 337 | $96.49 | 11,958.0000 | 51,397,000 | 2.74% | 0.00% |
| May 16, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | F | Common Stock | 318 | $94.80 | 11,640.0000 | 51,397,000 | 2.66% | 0.00% |
| May 15, 2024 | Maunsell Farris Maryanne | VP, Chief Accounting Officer | F | Common Stock | 73 | $96.49 | 557.0000 | 51,397,000 | 11.59% | 0.00% |
| May 15, 2024 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 416 | $96.49 | 31,856.0000 | 51,397,000 | 1.29% | 0.00% |
| May 16, 2024 | Basil Michelle L | EVP and General Counsel | F | Common Stock | 446 | $94.80 | 31,410.0000 | 51,397,000 | 1.40% | 0.00% |
| May 16, 2024 | Basil Michelle L | EVP and General Counsel | S | Common Stock | 985 | $96.14 | 30,425.0000 | 51,397,000 | 3.14% | 0.00% |
| May 15, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 241 | $96.49 | 15,860.0000 | 51,397,000 | 1.50% | 0.00% |
| May 16, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 252 | $94.80 | 15,608.0000 | 51,397,000 | 1.59% | 0.00% |
| May 16, 2024 | Strong Stewart W | President, Global Hospital | M | Common Stock | 2410 | $57.60 | 18,018.0000 | 51,397,000 | 15.44% | 0.00% |
| May 16, 2024 | Strong Stewart W | President, Global Hospital | F | Common Stock | 1677 | $96.14 | 16,341.0000 | 51,397,000 | 9.31% | 0.00% |
| May 16, 2024 | Strong Stewart W | President, Global Hospital | S | Common Stock | 733 | $96.04 | 15,608.0000 | 51,397,000 | 4.49% | 0.00% |
| May 16, 2024 | Strong Stewart W | President, Global Hospital | M | Non-qualified Stock Option (Right to Buy) | 2410 | $0.00 | 4,821.0000 | 51,397,000 | 33.33% | 0.00% |
| May 15, 2024 | Galvin Roy | President, Global Plasma & BC | F | Common Stock | 214 | $96.49 | 4,538.0000 | 51,397,000 | 4.50% | 0.00% |
| May 6, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | S | Common Stock | 2305 | $95.00 | 12,295.0000 | 51,397,000 | 15.79% | 0.00% |
| May 2, 2024 | DArecca James | EVP, Chief Financial Officer | F | Common Stock | 432 | $93.33 | 13,670.0000 | 51,397,000 | 3.06% | 0.00% |
| April 15, 2024 | Lingamneni Anila | EVP, Chief Technology Officer | F | Common Stock | 184 | $84.88 | 14,311.0000 | 51,397,000 | 1.27% | 0.00% |
| March 11, 2024 | Simon, Christopher | President & CEO | G | Common Stock | 38900 | $0.00 | 257,546.0000 | 51,420,000 | 13.12% | 0.08% |